1% pimecrolimus cream vs betamethasone 17‐valerate 0.1%
Clearing or excellent improvement · people with discoid lupus erythematosus
1 finding from 1 review
- no estimate extracted1 study · 10 participantsGRADE not reported
Findings
What do systematic reviews say?
5 questions · 5 findings · 1 reviews
No studies found 4 · 80%GRADE not reported 1 · 20%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%
1% pimecrolimus cream vs betamethasone 17‐valerate 0.1%
At least 50% reduction in erythema · people with discoid lupus erythematosus
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
1% pimecrolimus cream vs betamethasone 17‐valerate 0.1%
Quality of life measure · people with discoid lupus erythematosus
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
1% pimecrolimus cream vs betamethasone 17‐valerate 0.1%
Relapse · people with discoid lupus erythematosus
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
1% pimecrolimus cream vs betamethasone 17‐valerate 0.1%
Adverse events of medication, leading to discontinuation or significant morbidity · people with discoid lupus erythematosus
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found